Inventor · disambiguated record
Nicolas Baurin
Also filed as: BAURIN NICOLAS
13 granted patents·14 pending applications·140 citations·filing 2008–2022
92Inventor score
Top patents by PatentIndex Score
27 records- 0195US8614299B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideBAURIN NICOLAS·Filed 2010·Granted Dec 24, 2013·56 cites·27 claims
- 0294US9221917B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Dec 29, 2015·23 cites·21 claims
- 0394US9181349B2Dual variable region antibody-like binding proteins having cross-over binding region orientationBAURIN NICOLAS·Filed 2013·Granted Nov 10, 2015·29 cites·26 claims
- 0484US8647622B2Humanized anti-CXCR5 antibodies, derivatives thereof and their useLEE RENATA·Filed 2008·Granted Feb 11, 2014·9 cites·9 claims
- 0583US8852593B2Antagonist antibodies and their fab fragments against GPVI and uses thereofBAURIN NICOLAS·Filed 2010·Granted Oct 7, 2014·8 cites·8 claims
- 0680US10112991B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2016·Granted Oct 30, 2018·2 cites·30 claims
- 0778US9376494B2Antibodies to kallidin and des-Arg9-kallidinSANOFI SA·Filed 2013·Granted Jun 28, 2016·3 cites·13 claims
- 0877US9845363B2Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereofSANOFI SA·Filed 2014·Granted Dec 19, 2017·5 cites·10 claims
- 0976US9382312B2Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2013·Granted Jul 5, 2016·2 cites·26 claims
- 1075US10465002B2Nucleic acids encoding antibodies to Kallidin and des-Arg10-Kallidin and host cells comprising the sameSANOFI SA·Filed 2017·Granted Nov 5, 2019·1 cites·15 claims
- 1173US2021189011A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2020·Application pending·0 cites
- 1272US9879079B2Methods for treating pain using antibodies to Kallidin and des-Arg10-KallidinSANOFI SA·Filed 2016·Granted Jan 30, 2018·1 cites·15 claims
- 1370US2023015181A1Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses ThereofSANOFI SA·Filed 2022·Application pending·0 cites
- 1470US2020115441A1Methods for treating inflammation using antibodies to kallidin and des-arg10-kallidinSANOFI SA·Filed 2019·Application pending·0 cites
- 1565US2018155450A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2017·Application pending·0 cites
- 1660US9234039B2Peptide or peptide complex binding to ALPHA2 integrin and methods and uses involving the sameCORVEY CARSTEN·Filed 2011·Granted Jan 12, 2016·1 cites·17 claims
- 1760US2016200811A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationSANOFI SA·Filed 2015·Application pending·0 cites
- 1860US2012251541A1Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region OrientationBAURIN NICOLAS·Filed 2012·Application pending·0 cites
- 1960US2019119365A1Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptideSANOFI SA·Filed 2018·Application pending·0 cites
- 2057US9441040B2Antagonist antibodies and their fab fragments against GPVI and uses thereofSANOFI SA·Filed 2014·Granted Sep 13, 2016·0 cites·15 claims
- 2156US2019359729A1Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses ThereofSANOFI SA·Filed 2019·Application pending·0 cites
- 2251US2018155444A1Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses ThereofSANOFI SA·Filed 2017·Application pending·0 cites
- 2350US2011150903A1Fgf-r4 receptor-specific antagonistsSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 2444US2014335102A1In silico affinity maturationSANOFI SA·Filed 2012·Application pending·0 cites
- 2541US2013108641A1Anti-gitr antibodiesBAURIN NICOLAS·Filed 2012·Application pending·0 cites
- 2640US2016176970A1Peptide or peptide complex binding to alpha2 integrin and methods and uses involving the sameSANOFI SA·Filed 2015·Application pending·0 cites
- 2732US2015210729A1Macrolide derivatives, preparation thereof and therapeutic use thereofSANOFI SA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Baurin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →